Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Carolyn Saccente

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentPeds Pediatrics, College of Medicine
DivisionPeds Hematology
Address ACH Sturgis Building
800 Marshall Street
Mail Slot # 512-10
Little Rock AR 72202
Phone501-364-1494
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    034736     (SACCENTE, CAROLYN S)Sep 1, 2017 - Aug 31, 2022
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    034738     (SACCENTE, CAROLYN S)Sep 1, 2017 - Aug 31, 2022
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    GR034122     (SACCENTE, CAROLYN S)Sep 1, 2017 - Aug 31, 2022
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    34676     (SACCENTE, CAROLYN S)Aug 1, 2017 - Jun 30, 2022
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    ACRI # 034674     (SACCENTE, CAROLYN S)Aug 1, 2017 - Jun 30, 2022
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    ACRI#034674     (SACCENTE, CAROLYN S)Aug 1, 2017 - Jun 30, 2022
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator
    GR034113     (SACCENTE, CAROLYN S)Aug 1, 2017 - Jun 30, 2022
    UAMS ACHRI Flow Through
    No FP attached
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. DeBaun, MR, Sarnaik, SA, Rodeghier, MJ, Minniti, CP, Howard, TH, Iyer, RV, Inusa, B, Telfer, PT, Kirby-Allen, M, Quinn, CT, Bernaudin, F, Airewele, G, Woods, GM, Panepinto, JA, Fuh, B, Kwiatkowski, JK, King, AA, Rhodes, MM, Thompson, AA, Heiny, ME, Redding-Lallinger, RC, Kirkham, FJ, Sabio, H, Gonzalez, CE, Saccente SL, Kalinyak, KA, Stouse, JJ, Fixier, JM, Gordon, MO, Miller, JP, Noelzel, MJ, Ichord, RN, Casella,JF. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex and relative high systolic blood pressure. Blood. 2012; 119(16):3684-90.
    2. Lebras MH, Saccente CS, Saylors RL, Perry TT, Jones SM, Scurlock AM. Modified Desensitization Protocol Using Two Formulations of L-Asparaginase in a Pediatric Patient with Recurrent Acute Lymphoblastic Leukemia (ALL). 2006; 117:S230.
    3. Stine KC, Saylors RL, Saccente CS, McClain KL, Becton DL. Efficacy of Continuous Infusion 2-CDA (Cladribine) in Pediatric Patients with Langerhans Cell Hystiocytosis. Pediatr Blood and Cancer. 2004; 43:81-84.
    4. Orringer, EP, Casella, JF, Ataga, JF, Koshy, M, Adams-Graves, P, Luchtman-Jones, L, Wun, T, Watanabe, M, Shafer, F, Kutlar, A, Abboud, M, Steinberg, M, Adler, B, Swerdlow, P, Terregino, C, Saccente SL, Files, B, Ballas, S, Brown, R, Wojtowicz-Praga, S, Grindel, JM. Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease. JAMA. 2001; 286:2099-2106.
    5. Jones, AM, Seibert, JJ, Nichols, FT, Kinder, DL, Cox, K, Luden, J, Carl, EM, Brambilla, D, Saccente SL. Comparison of transcranial Doppler Imaging (TCDI) and transcranial Doppler (TCD) in children with sickle cell anemia. Ped Rad. 2001; 31:461-469.
    6. Fuller J, Davis P, Dancer J, Gentry B, Montague J, Jackson J, Saccente SL. Comparison of attitudes about communication in children and adolescents with sickle cell disease. Perceptual & Motor Skills. 1998; 87(2):634.
    7. Sanders C, Gentry B, Davis P, Jackson J, Saccente CS. Reading, Writing, and Vocabulary Skills of Children with Strokes due to Sickle Cell Disease. 1997; 85:477-478.
    8. Saccente CS, Wang Y, Howard TH. MAP2C and Tau Expression Correlate in Vivo and in Vitro with Neuroblastoma Differentiation. 1994.
    9. Saccente CS, Kohaut EC, Berkow RL. Prevention of Tumor Lysis Syndrome Using Continuous Veno-Venous Hemofiltration. 1993; 82:995a.
    10. Saccente CS, Kohaut EC, Berkow RL. Prevention of Tumor Lysis Syndrome Using Continuous Veno-Venous Hemofiltration. Prev. Tum. Lys. Synd. w/cont. veno-venous hemogiltr. 9:569-573.
    Same Department Expand Description
    Search Department